Rexam Healthcare Expands Manufacturing for Drug Delivery Systems - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Rexam Healthcare Expands Manufacturing for Drug Delivery Systems


Rexam Healthcare, a subsidiary of the UK group Rexam, will expand manufacturing capabilities at its French site in Le Tréport, Seine Maritime, the company announced in a press release.

This site specializes in drug delivery systems, including the recently introduced Advancia pump for the nasal-spray sector. The plant expansion and the Advancia project, which is supported by the European Regional Development Fund in Normandy, will add approximately fifty jobs.
 
Along with other site improvements, the manufacturing expansion will include a production building with a 2900-square meter cleanroom and 1500 square meters housing the machine and mold maintenance workshops, metrology unit, laboratory, and administrative premises. The cleanroom is expected to open in November 2013 and full inauguration of the site is expected in early 2014.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes
Sandoz Wins Biosimilar Filing Race

Click here